Salmeterol Xinafoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 20 USDMF, 16 CEP/COS, 1 JDMF, 11 EU WC, 14 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

225 FDF Dossiers, 23 FDA Orange Book, 143 Europe, 12 Canada, 2 Australia, 22 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

RELATED EXCIPIENT COMPANIES

1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 BASF, 2 DFE Pharma, 17 Kerry, 2 Microlex e.U, 1 Pluviaendo, 1 Roquette, 2 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders, 6 Co-Processed Excipients, 6 Granulation, 6 Direct Compression, 1 Coating Systems & Additives, 1 Controlled & Modified Release, 1 Parenteral